Strategy and Standardized Operation Procedure for the Application of Absorbable Dural Sealant Based on the Classification and Grading System of Dural Incision

密封剂 外科 分级(工程) 医学 工程类 材料科学 土木工程 复合材料
作者
Caizhi Ma,Zhe Han,Shouji Zhang,Jia Li,Huizhong Chi,Qingtong Wang,Deze Jia,Kailiang Zhang,Zichao Feng,Hongwei Wang,Jie Gong,Shilei Ni,Xueen Li,Gang Li,Hao Xue
标识
DOI:10.2139/ssrn.4574775
摘要

Background: Durotomy and suturing are very important steps in neurosurgery, as defects in the dura mater can lead to postoperative complications. Different dural incisions and dural defects affect the effectiveness of dural suture, but absorbable dural sealant can aid in watertight suturing of the dura mater. Therefore, we propose a classification and grading system for dural incisions and a standardized operation procedure using absorbable dural sealant to help neurosurgeons improve the effectiveness of dural closure.Methods: According to the type and degree of suture of the dural incision, a classification and grading system of dural incisions was proposed, as well as a standardized operation process for the application of absorbable dural sealant based on the system. Then, we retrospectively analyzed the clinical data (postoperative subcutaneous or epidural drainage volume, rate of subcutaneous effusion formation and rate of antibiotic usage) of patients who were treated with and without absorbable dural sealant. We used these data to verify the effectiveness of absorbable dural sealant in blocking the dura mater and its standardized use.Findings: According to the type of dural incision and the degree of suture of the dural incision, we divided the dural incision into 5 types and 5 grades. Based on the classification and grading system of dural incision, the absorbable dural sealant was applied rationally and in a standardized operation to seal the dural incision tightly. Here, we retrospectively analyzed the clinical data of patients who were treated with and without absorbable dural sealant. The results of the analysis are as follows. In our own group, the subcutaneous or epidural drainage volume of patients who were not treated with dural sealant was significantly higher than that of patients were treated with dural sealant (P<0.001). In our own group, the rate of subcutaneous fluid formation in patients were not treated with dural sealant was 43%, which was higher than that in patients who were treated with dural sealant (19.8%) (P<0.001). In our own group, the rate of antibiotic usage in patients who were not treated with dural sealant was 42.2%, which was higher than that in patients who were treated with dural sealant (20.6%) (P<0.001). The subcutaneous or epidural drainage volume of patients who were treated with dural sealant in our own group was significantly lower than that in other groups (P<0.001). The rate of antibiotic usage in patients who were treated with dural sealant was 20.6% in our own group, which was lower than that in patients who were treated with dural sealant (35.2%) in the other groups (P=0.007).Interpretation: The use of absorbable dural sealant can improve the watertight suturing of the dura mater and reduce the formation of postoperative subcutaneous effusion, postoperative infection and other complications. In addition, the use of absorbable dural sealant should be standardized; otherwise, the effect of the product on closing the dural incision will be reduced. The classification and grading system for dural incisions and our standardized operation procedure for the application of absorbable dural sealant are scientific and rigorous and have great clinical significance and application prospects. We believe that this standard can provide the basis for more clinicians to operate.Funding: This study was funded by Taishan Pandeng Scholar Program of Shandong Province (tspd20210322), Fundamental Research Funds for the Central Universities (2022JC019), Jinan Science and Technology Bureau of Shandong Province (2021GXRC029), Research on the future application prospect of a classical gene marker kit (6010122006), Youth Taishan Scholar Program of Shandong Province(tsqn202211316), Clinical application of POCT diagnosis technology for rapid molecular pathology in brain glioma (National Clinical Practical New Technology Project).Declaration of Interest: None of the authors have conflicts of interest to disclose. None of the authors have financial relationships relevant to this article to disclose.Ethical Approval: This study was approved by the ethics committees of Qilu Hospital of Shandong University. All informed consent forms permitting treatment with implantable consumables have been stored. All patient-relevant information was anonymous and deidentified.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
汉堡包应助mmol采纳,获得10
3秒前
gao完成签到,获得积分10
3秒前
Hiraeth完成签到 ,获得积分10
4秒前
科研通AI5应助ran采纳,获得10
4秒前
herdwind完成签到,获得积分10
4秒前
小蘑菇应助白青采纳,获得10
5秒前
6秒前
猪伱平安完成签到,获得积分10
6秒前
111完成签到 ,获得积分20
7秒前
7秒前
8秒前
zhl完成签到,获得积分10
9秒前
9秒前
学呀学发布了新的文献求助10
12秒前
CipherSage应助astalavista采纳,获得10
12秒前
老李完成签到,获得积分10
13秒前
13秒前
13秒前
臭小子发布了新的文献求助10
14秒前
猪伱平安发布了新的文献求助10
15秒前
卡夫卡完成签到 ,获得积分10
16秒前
烜66发布了新的文献求助10
16秒前
研友_Zr2mxZ发布了新的文献求助30
16秒前
细致且入微完成签到,获得积分10
16秒前
愤怒的qiang完成签到,获得积分10
17秒前
dada完成签到,获得积分10
18秒前
18秒前
19秒前
深情安青应助迷路的手机采纳,获得10
19秒前
Lee完成签到,获得积分20
21秒前
刘明生发布了新的文献求助20
21秒前
22秒前
23秒前
23秒前
KX发布了新的文献求助10
23秒前
BYN完成签到 ,获得积分10
25秒前
Zzz发布了新的文献求助10
26秒前
26秒前
科研牛马发布了新的文献求助10
27秒前
高分求助中
All the Birds of the World 4000
Production Logging: Theoretical and Interpretive Elements 3000
Les Mantodea de Guyane Insecta, Polyneoptera 2000
Am Rande der Geschichte : mein Leben in China / Ruth Weiss 1500
CENTRAL BOOKS: A BRIEF HISTORY 1939 TO 1999 by Dave Cope 1000
Machine Learning Methods in Geoscience 1000
Resilience of a Nation: A History of the Military in Rwanda 888
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3737471
求助须知:如何正确求助?哪些是违规求助? 3281236
关于积分的说明 10023845
捐赠科研通 2997978
什么是DOI,文献DOI怎么找? 1644888
邀请新用户注册赠送积分活动 782418
科研通“疑难数据库(出版商)”最低求助积分说明 749782